California Public Employees Retirement System
ARQT icon

California Public Employees Retirement System’s Arcutis Biotherapeutics ARQT Stock Holding History

California Public Employees Retirement System’s Portfolio ARQT Stock Details ARQT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-36,700
Closed -$1.06M – 1646
2021
Q1 		$1.06M Sell
36,700
-3,904
-10% -$122K ﹤0.01% 2450
2020
Q4 		$1.14M Sell
40,604
-277
-0.7% -$6.79K ﹤0.01% 2381
2020
Q3 		$1.2M Buy
40,881
+19,885
+95% +$531K ﹤0.01% 2146
2020
Q2 		$635K Buy
+20,996
New +$607K ﹤0.01% 2535

Other funds holding ARQT

FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

California Public Employees Retirement System's ARQT Position: Q2 2021 in Review

California Public Employees Retirement System sold out of Arcutis Biotherapeutics (ARQT) in Q2 2021, closing a stake of 36,700 shares — an estimated $1.06M sold.

California Public Employees Retirement System first reported a position in ARQT in Q2 2020 and held it in 4 quarters. The position peaked at $1.2M in Q3 2020. 102 funds tracked by Wall St. Rank hold ARQT as of Q2 2021.

  • California Public Employees Retirement System reported no remaining Arcutis Biotherapeutics position as of Q2 2021 after selling out during the quarter.
  • California Public Employees Retirement System sold 36,700 Arcutis Biotherapeutics shares in Q2 2021, an estimated $1.06M.
  • California Public Employees Retirement System first reported a position in Arcutis Biotherapeutics in Q2 2020 and held it in 4 quarters.
  • California Public Employees Retirement System's Arcutis Biotherapeutics position peaked at $1.2M in Q3 2020.
  • 102 funds tracked by Wall St. Rank held Arcutis Biotherapeutics as of Q2 2021.

Based on California Public Employees Retirement System's 13F filing for Q2 2021, filed 13 Aug 2021.